UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): June 17, 2011
PolyMedix, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
Delaware |
|
000-51895 |
|
27-0125925 |
|
(State or Other Jurisdiction of Incorporation or Organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification Number) |
|
|
|
|
|
170 N. Radnor-Chester Road; Suite 300 Radnor, Pennsylvania |
|
19087 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
(484) 598-2400
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders. |
On June 17, 2011, PolyMedix, Inc. (the “Company”) held its 2011 Annual Meeting of Shareholders. At the meeting, the shareholders voted on: (1) the election of seven directors, (2) a non-binding, advisory vote regarding the compensation of the Company’s named executive officers, (3) a non-binding, advisory vote regarding the frequency of advisory votes on the compensation of the Company’s named executive officers and (4) the ratification of the appointment of Deloitte and Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2011. The voting results on these proposals were as follows:
Proposal 1: Election of Seven Directors
|
Director |
Votes For |
Withheld |
Broker Non-votes |
|
Nicholas Landekic |
27,578,328 |
12,563,664 |
36,683,807 |
|
Brian Anderson |
28,502,057 |
11,819,935 |
36,683,807 |
|
Richard Bank, M.D. |
29,528,207 |
10,793,785 |
36,683,807 |
|
Michael Lewis, Ph.D. |
29,659,707 |
10,662,285 |
36,683,807 |
|
Stefan Loren, Ph.D. |
29,636,707 |
10,685,285 |
36,683,807 |
|
Shaun O’Malley |
29,576,757 |
10,745,235 |
36,683,807 |
|
Douglas Swirsky |
29,518,457 |
10,803,535 |
36,683,807 |
Proposal 2: Advisory, non-binding vote on the compensation of the Company’s named executive officers
|
Votes For |
Votes Against |
Abstentions |
Broker Non-votes |
|
30,433,628 |
8,561,207 |
1,327,157 |
36,683,807 |
Proposal 3: Advisory, non-binding vote on the frequency of shareholder advisory votes on the compensation of the Company’s named executive officers
|
One-Year |
Two-Year |
Three-Year |
Abstentions |
Broker Non-votes |
|
22,942,063 |
3,311,509 |
12,984,150 |
1,084,270 |
36,683,807 |
Proposal 4: Ratification of the appointment of Deloitte and Touche LLP as the Company’s independent registered public accountant firm for the year ending December 31, 2011
|
Votes For |
Votes Against |
Abstentions |
|
74,879,141 |
584,625 |
1,542,033 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
PolyMedix, Inc. |
||
|
|
|
|
||
|
Date: June 20, 2011 |
|
By: |
|
/s/ Edward F. Smith |
|
|
|
|
|
|
|
|
|
|
|
Edward F. Smith Vice President, Finance and Chief Financial Officer |